Changes, limitations, and prospects of adult height in GH treatment for Japanese GHD patients

For the treatment of pituitary dwarfism (called pituitary short stature in 1987 and renamed as growth hormone deficiency [GHD] in 1993), pituitary-derived human growth hormone (phGH) was approved in 1975, and recombinant hGH (rhGH) was approved in 1988. Adult height in patients with isolated GH defi...

Descripción completa

Detalles Bibliográficos
Autor principal: Tanaka, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637418/
https://www.ncbi.nlm.nih.gov/pubmed/36405437
http://dx.doi.org/10.1297/cpe.2022-0034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637418/
https://www.ncbi.nlm.nih.gov/pubmed/36405437
http://dx.doi.org/10.1297/cpe.2022-0034

Ejemplares similares